Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6E0E

Crystal structure of Glucokinase in complex with compound 6

Summary for 6E0E
Entry DOI10.2210/pdb6e0e/pdb
DescriptorGlucokinase, alpha-D-glucopyranose, 2-({2-[(4-methyl-1,3-thiazol-2-yl)amino]pyridin-3-yl}oxy)benzonitrile, ... (4 entities in total)
Functional Keywordsglucokinase, glucokinase activator, structure-aided design, structure-based design, type ii diabetes, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight50752.55
Authors
Primary citationHinklin, R.J.,Baer, B.R.,Boyd, S.A.,Chicarelli, M.D.,Condroski, K.R.,DeWolf Jr., W.E.,Fischer, J.,Frank, M.,Hingorani, G.P.,Lee, P.A.,Neitzel, N.A.,Pratt, S.A.,Singh, A.,Sullivan, F.X.,Turner, T.,Voegtli, W.C.,Wallace, E.M.,Williams, L.,Aicher, T.D.
Discovery and preclinical development of AR453588 as an anti-diabetic glucokinase activator.
Bioorg.Med.Chem., 28:115232-115232, 2020
Cited by
PubMed Abstract: Glucose flux through glucokinase (GK) controls insulin release from the pancreas in response to high levels of glucose. Flux through GK is also responsible for reducing hepatic glucose output. Since many individuals with type 2 diabetes appear to have an inadequacy or defect in one or both of these processes, identifying compounds that can activate GK could provide a therapeutic benefit. Herein we report the further structure activity studies of a novel series of glucokinase activators (GKA). These studies led to the identification of pyridine 72 as a potent GKA that lowered post-prandial glucose in normal C57BL/6J mice, and after 14d dosing in ob/ob mice.
PubMed: 31818630
DOI: 10.1016/j.bmc.2019.115232
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.7 Å)
Structure validation

237992

数据于2025-06-25公开中

PDB statisticsPDBj update infoContact PDBjnumon